“Method Development And Validation Of Ubrogepant In Bulk And Pharmaceutical Dosage Form By Using Rp-Hplc”, Journal of Pharmaceutical Negative Results, pp. 7690–7696, Dec. 2022, doi: 10.47750/pnr.2022.13.S07.929.